Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

26–50 of 1,630 articles for phase II

Then save them, add them to a collection or cite them together.
  1. Review article · 13 Feb 2019

    Final Efficacy Results of a Randomized Phase II Study of Recombinant Interleukin-21 Compared to Dacarbazine in Patients with Recurrent or Metastatic Melanoma

    Journal of Oncology Research and Treatment · Volume 4, Issue 1

    cytokine with antitumour activity dependent on NK cells or CD8+ T cells. A previous phase II study demonstrated an overall response rate (ORR) of 22.5% in previously untreated patients with ... metastatic melanoma. We…

  2. Research article · 2019

    Final Efficacy Results of a Randomized Phase II Study of Recombinant Interleukin-21 Compared to Decarbonize in Patients with Recurrent or Metastatic Melanoma

    International Journal of Inflammation, Cancer and Integrative Therapy · Volume 6, Issue 3

    derived cytokine with antitumour activitydependent on NK cells or CD8+ T cells. A previous phase II study demonstratedan overall response rate (ORR) of 22.5% in previously untreated patients withmetastatic melanoma…

  3. Research article · 2017

    Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma

    Immunotherapy: Open Access · Volume 3, Issue 1

    release, activation of Langerhans cells, and T-cell responses. An extended evaluation of phase II data of the patient cohorts with/without skin reactions within the first treatment cycle after ... failure of standard…

  4. Other · 23 Jul 2016

    Monitoring rules for toxicity in Phase II oncology trials

    Clinical Investigation · Volume 5, Issue 4

    usually accrued in Phase I oncology trials, the maximum tolerated dose and the recommended Phase II dose of the treatment regimen can be imprecisely defined. This may lead to testing ... treatment regimens in Phase II…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels